Zolpidem in Parkinson's disease

Lancet. 1997 Apr 26;349(9060):1222-3. doi: 10.1016/S0140-6736(05)62416-6.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Globus Pallidus / drug effects
  • Humans
  • Hypnotics and Sedatives / therapeutic use*
  • Middle Aged
  • Motor Skills / drug effects
  • Motor Skills / physiology
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Placebos
  • Pyridines / therapeutic use*
  • Receptors, GABA / drug effects
  • Substantia Nigra / drug effects
  • Zolpidem

Substances

  • Antiparkinson Agents
  • Hypnotics and Sedatives
  • Placebos
  • Pyridines
  • Receptors, GABA
  • Zolpidem